Form 4 for WST West Pharmaceutical Services
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-11 · accession 0001127602-24-009590 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-12 | 2024-03-11 | WST | Winters Chad | VP, CAO | S - Sale+OE | $358.82 | -815 | 1,309 | -38% | -$292.4K |
| D | 2024-03-12 | 2024-03-11 | WST | Winters Chad | VP, CAO | M - OptEx | $173.22 | +675 | 2,124 | +47% | +$116.9K |
| D | 2024-03-12 | 2024-03-11 | WST | Winters Chad | VP, CAO | M - OptEx | $0.00 | -675 | 896 | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-11 | S | D | 815 | $358.82 | 1,308.70 | D | — | — | (F1) 2021 PSUs (PP20) award vesting net of taxes withheld. |
| 2 | Common | Common Stock | 2024-03-11 | M | A | 675 | $173.22 | 2,123.70 | D | — | — | (F1) 2021 PSUs (PP20) award vesting net of taxes withheld. |
| 3 | Derivative | Stock Options (Right to Buy) | 2024-03-11 | M | D | 675 | $0.00 | 896 | D | $173.22 · 2021-02-18 to 2030-02-18 | 675 Stock Options (Right to Buy) |